What is the typical appearance of conjunctival metastases (mets)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Appearance of Conjunctival Metastases

Conjunctival metastases typically appear as solitary, yellowish masses on the bulbar or palpebral conjunctiva, often accompanied by intense conjunctival injection, and should be considered in any patient with a history of systemic cancer presenting with a new conjunctival lesion. 1, 2

Clinical Characteristics

Color and Morphology

  • Yellow coloration is the most common presentation, occurring in approximately 70% of cases, though lesions may also appear red (20%) or brown (10%) 2
  • The lesions can present as flat or nodular masses on the bulbar conjunctiva (most common), palpebral conjunctiva, limbus, or forniceal conjunctiva 1, 2
  • Sebaceous carcinoma, which can mimic metastatic disease, may appear as a subconjunctival multilobulated yellow mass or yellowish discoloration of the tarsal plate 1, 3

Associated Clinical Signs

  • Intense bulbar conjunctival injection is a characteristic finding that should raise suspicion for neoplastic disease 1
  • Conjunctival scarring may be present 1
  • Mucopurulent discharge can occur 1
  • The lesions are typically solitary (80% of cases) rather than multifocal 2

Primary Tumor Sources

  • Breast carcinoma is the most common primary source (40% of cases), followed by lung cancer (20%), cutaneous melanoma (20%), and laryngeal carcinoma 2
  • Metastases typically appear 8-130 months after the primary tumor diagnosis, with a mean of 44 months 2

Critical Diagnostic Features Requiring Urgent Evaluation

Warning Signs

  • Enlargement of the lesion, development of blood vessels, or thickening warrant immediate biopsy 4
  • Recurrence in the same location, particularly in elderly patients with history of multiple excisions 4
  • Any conjunctival mass in a patient with prior systemic cancer should be presumed metastatic until proven otherwise 2

Evaluation Approach

  • Slit-lamp biomicroscopy is mandatory to assess location, depth, elevation, and vascular characteristics 4, 3
  • Biopsy should be performed for atypical features or in patients with known systemic malignancy 4

Clinical Context and Prognosis

  • Conjunctival metastases indicate advanced systemic disease, with 80% of patients having concurrent metastases to other ocular structures or organs 2
  • Mean survival after diagnosis of conjunctival metastasis is only 9 months (range 2-26 months), though one case report documented death within 3 weeks 2, 5
  • The presence of conjunctival metastasis represents a poor prognostic indicator requiring immediate systemic evaluation and oncologic consultation 2, 5

Common Pitfall

  • Do not misdiagnose sebaceous carcinoma or metastatic disease as chronic blepharoconjunctivitis, as this delays appropriate treatment and worsens outcomes 1, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Metastatic tumours to the conjunctiva: report of 10 cases.

The British journal of ophthalmology, 1996

Guideline

Management of Conjunctival Metastases

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Conjunctival Lesions Diagnosis and Evaluation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Breast cancer metastasis to the conjunctiva.

Vojnosanitetski pregled, 2013

Guideline

Causes and Risk Factors for Conjunctival Hemorrhages

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.